Shows
Dr. Howard Smith ReportsRSV Prevention Pays Off BigVidcast: https://www.instagram.com/p/DTdqupiEeau/Maternal RSV vaccination during pregnancy and the use of the RSV antibody nirsevimab for newborns reduces the incidence of RSV infections by more than two-thirds. Researchers at the CDC and leading children’s hospitals studied 5,029 babies during the 2024–2025 RSV season and published their results in the journal JAMA Pediatrics.Among infants younger than six months, maternal RSV vaccination was 70% effective and nirsevimab was 81% effective. RSV hospitalization rates were reduced 41% to 51% among newborns and infants compared with previous rates. The highe...
2026-01-1301 min
A Moment with MarleyRespiratory Syncytial Virus (RSV)In this episode of A Moment with Marley, we are diving into a topic that’s especially relevant as we move through colder months, Respiratory Syncytial Virus, or RSV.
First things first, what is RSV? RSV is a respiratory infection that affects the lungs and airways. It’s especially known for causing severe issues in young children, babies, and older adults with weakened immune systems.
Like many viruses, RSV spreads easily. It passes through droplets in the air when an infected person coughs, sneezes, or even talks. You can also catch it from surfaces that have...
2026-01-1303 min
Healthy Mom Healthy Baby TennesseeEO: 206 RSV Vaccines for Moms and Babies, Part 1Resources:ACOG:https://www.acog.org/programs/immunization-infectious-disease-public-health/tools-and-resources/infographic-respiratory-syncytial-virus?utm_source=redirect&utm_medium=web&utm_campaign=inthttps://www.acog.org/programs/immunization-infectious-disease-public-health/tools-and-resources/infographic-rsv-vaccine-top-3-reasonsCDChttps://www.cdc.gov/rsv/vaccines/index.htmlSociety for Maternal Fetal Medicinehttps://www.highriskpregnancyinfo.org/vaccine-guide-for-pregnancy-2024https://www.smfm.org/rsvVideo: https://youtu.be/BnpKnTlWZaI?si=mN4bxvw-S3NcAaKzHealthy Children.orghttps://www.healthychildren.org/English/family-life/Media/Pages/follow-pediatricians-for-trustworthy-content-on-childrens-health.aspxACOG:
2025-12-2619 min
Clinical CapsulesPreventing Respiratory Syncytial Virus (RSV): Immunization UpdatesRSV prevention is more important than ever, and pharmacy teams are on the front lines. In this episode, TRC Healthcare Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children. You’ll also hear practical tips on the best time to vaccinate patients, co-administration with other vaccines, product nuances, and safety considerations to help confidently guide patients through RSV prevention this season.This is an excerpt from our October 2025 Pharmacy Essential Updates continuing education webinar series.******
2025-12-2320 minDr. Howard Smith ReportsWARNING: Childhood RSV Infection Boosts Asthma RiskVidcast: https://www.instagram.com/p/DSBTBdjADuG/Infants developing RSV during the first 6 months of life are more than three times more likely to develop bronchial asthma later on. This the result of a retrospective Belgian study of nearly 1.5 million children published in the journal Science Immunology.The data showed that infants born to parents without a history of asthma and admitted to hospitals for an RSV infection had a 3.3 fold higher risk of later asthma. Those with less severe RSV case not requiring admission had ne...
2025-12-0901 min
Pediagogy™RSV immunizationsWondering how to best protect your patients or your own baby this winter from RSV? We'll go over the different preventative options against RSV in today's episode!This episode was written by pediatricians Tammy Yau and Lidia Park with content support from Kenneth Yau (general pediatrics). Pediatricians Tammy and Lidia take full responsibility for any errors or misinformation.Follow us on Twitter/X @Pediagogypod, Instagram/Threads @pediagogy, Bluesky @pediagogypodcast.bluesky.social, and connect with us at pediagogypod@gmail.comKey Points:RSV immunizations...
2025-12-0110 min
Funny Medicine PodcastRSV In Babies: Pediatrician Explains The Virus Filling ERs RSV in babies, kids, and older adults explained by a board certified pediatrician and a medical researcher who deal with RSV season every single day in clinic. In this Funny Medicine Podcast episode, we talk through real numbers, real stories, and the new RSV vaccines and antibodies for 2024 2025 without fear mongering or medical jargon overload. You hear Dr Yvy, pediatrician, and Julz, medical researcher and mom, break down: • What RSV is in plain language, from “runny nose” to bronchiolitis and pneumonia • RSV symptoms in babies, toddlers, older kids, adults, and seniors • Why RSV se...
2025-11-2556 min
The Buzz: Parenting and Pediatrics with Dr. BeeEp 73: How to deal with RSV infections!Stay tuned at the end for a peek at Dr. Bee's new grandson, Ezriel! Respiratory Syncytial Virus or RSV can cause anything from a mild cold to a severe lung infection. It's RSV season once again so learn the warning signs of RSV infection, how to know if your child needs a trip to the doctor or ER, and what serious chronic disease may follow an RSV infection. Dr. Bee also covers the RSV vaccine for pregnant women, and RSV antibody preventives for newborns!
2025-11-2311 minDr. Howard Smith ReportsRSV Is Upon UsVidcast: https://www.instagram.com/p/DQ7izrDFySQ/As the weather cools, I’m sad to report that a new wave of respiratory syncytial virus, RSV, driven infections is again beginning to sweep across the US. These infections are sending increasing numbers of babies and toddlers to hospitals and to intensive care units. Besides RSV, cases of influenza and CoVid are also rising as we head into the peak respiratory virus season.What can you do to protect yourselves but especially your babies. Pregnant women should be vaccinated against RSV...
2025-11-1101 min
viroLOGISCH#17 – RSV: Warum es für Babys und Ältere gefährlich ist
Das Respiratorische Synzytial-Virus (RSV) ist ein weltweit verbreitetes Virus, das besonders für Babys und ältere Menschen gefährlich werden kann. In dieser Folge erklärt Florian Krammer, wie sich RSV verbreitet, welche Symptome typisch sind und warum Reinfektionen häufig vorkommen, obwohl sie meist milder verlaufen. Ein Schwerpunkt liegt auf der schweren Bronchiolitis bei Säuglingen und möglichen Spätfolgen wie Asthma. Auch die historische Entwicklung der Impfstoffforschung wird beleuchtet, von frühen Fehlschlägen bis hin zu den heute verfügbaren Impfungen und monoklonalen Antikörpern. Neben neuen Impfstoffen für Schwangere und über 60-Jährige geht es auch um...
2025-10-2920 min
VEC Vaccine NotesRespiratory Syncytial Virus (RSV) | Vaccine Education Center at Children’s Hospital of PhiladelphiaCharlotte Moser, Co-Director of the Vaccine Education Center at Children's Hospital of Philadelphia, talks about respiratory syncytial virus (RSV) and the tools available to protect against it. She addresses common questions and discusses the relative risks and benefits of this disease and the interventions available.
Find out:
- How many people, including young children, die from RSV each year
- What other vaccine-preventable viruses are in the same family as RSV
- Why symptoms can vary among different people
- How babies and elderly adults are protected differently against...
2025-10-0123 min
EMJ Podcast: Insights For Healthcare ProfessionalsRSV in Infants and Maternal Protection: Understanding the Burden of RSV In this first deep dive episode, Gonzalo Pérez Marc joins Saranya Ravindran to explore the global burden of RSV. Learn about hospitalisation and mortality rates, myths, seasonal changes, and long-term respiratory consequences. This episode highlights the urgent need for awareness and policy action in paediatric care. Timestamps: 00:00 – Introduction 00:44 – Pérez Marc's journey into RSV research 03:14 – Why RSV is not just a 'common cold' 05:47 – Mortality in newborns and infants 06:55 – Why is RSV still underestimated? 09:51 – The impact of climate change 12:37 – RSV and long-term lung disease ...
2025-09-1517 min
くつ王レディオ新生児を守るRSVワクチン：妊娠中の接種が乳児の重症化・入院を8割以上抑制する？最新研究と安全性を徹底解説 NEJMBivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsCitationNew England Journal of Medicine, 2023; 388:1451–1464論文の要約本多国間第3相二重盲検無作為化試験（MATISSE試験）は、妊娠24〜36週の妊婦に二価RSVプレフュージョンFタンパク質ワクチン（RSVpreF）を単回接種し、生後180日までの乳児におけるRSV関連下気道感染症の予防効果と安全性を評価した。対象と方法18か国、7,392名の妊婦を1:1でワクチン群（3,682例）またはプラセボ群（3,676例）に割り付け。主要評価項目は「生後90・120・150・180日までのRSV関連重症下気道感染（医療受診あり）」と「RSV関連下気道感染（医療受診あり）」の発症率。結果重症RSV-LRTD：90日以内は6例（ワクチン群） vs 33例（プラセボ群）、有効率81.8%（99.5%CI 40.6–96.3）、180日以内は有効率69.4%（97.58%CI 44.3–84.1）で主要評価の成功基準を満たした。RSV-LRTD（全重症度）：90日以内は有効率57.1%（99.5%CI 14.7–79.8）で基準未達、180日以内は有効率51.3%（97.58%CI 29.4–66.8）。RSV関連入院：90日以内は有効率67.7%、180日以内は56.8%。全原因の下気道感染やRSV以外の呼吸器感染には有意差なし。安全性妊婦の局所反応（接種部位痛 41% vs 10%）や一部の全身症状（筋肉痛・頭痛）はワクチン群でやや多かったが、多くは軽度〜中等度で一過性。重大な有害事象や乳児の安全性に懸念は認められなかった。臨床的意義妊娠後期のRSVpreFワクチン接種は、生後6か月間の乳児における重症RSV下気道感染および入院を有意に減少させ、安全性も良好であった。出生直後からの保護が可能であり、RSV流行期の乳児予防戦略において有望な選択肢となる。
2025-09-0910 minくつ王レディオ高齢者のRSV入院を83%削減！デンマークの大規模実世界研究が示すRSVpreFワクチンの真価と隠れたインパクト NEJMRSV Prefusion F Vaccine for Prevention of Hospitalization in Older AdultsCitationN Engl J Med. 2025 Aug 30; DOI:10.1056/NEJMoa2509810概要この研究（DAN-RSV試験）は、デンマークで行われた60歳以上を対象とする実用的第4相無作為化試験である。RSV前融合Fタンパク質ベースの二価ワクチン（RSVpreF）の高齢者における入院予防効果を評価した。デザイン：実用的オープンラベル並行群無作為化試験。対象者：131,379名（60歳以上のデンマーク居住者）。割付：ワクチン群65,688人、非接種群65,691人。評価：一次評価項目はRSV関連呼吸器疾患による入院。副次評価はRSV関連下気道疾患入院、全呼吸器疾患入院など。一次評価項目：RSV関連呼吸器疾患による入院はワクチン群で3例、対照群で18例。ワクチン有効性は83.3％（95％CI 42.9–96.9）。副次評価項目RSV関連下気道疾患による入院：ワクチン群1例、対照群12例。有効性91.7％。全呼吸器疾患による入院：ワクチン群284例、対照群335例。有効性15.2％。RSV関連心肺疾患入院：有効性84.2％。全下気道疾患入院：有効性20.8％。全死亡率は差がなかった（ワクチン群146例、対照群120例）。安全性：6週間の観察期間で重篤な有害事象はワクチン群1341件（2.1％）、対照群1669件（2.4％）と差はなかった。ワクチン関連と考えられたのは5件（ベル麻痺1、腹痛1、心膜炎2、頭痛/倦怠感2件）であった。ギラン・バレー症候群は確認されなかった。図1（p.6）：参加者のリクルート・無作為化・追跡の流れを示し、約131,000人が解析対象に含まれた。図2（p.10）：RSV関連呼吸器疾患による入院の累積発生率曲線を示し、ワクチン群のイベント発生率が顕著に低いことが示されている。図3（p.11）：年齢別、基礎疾患有無などのサブグループ解析を示し、多くのサブグループで一貫して有効性が確認された。表2（p.8）：一次・二次・探索的評価項目の発生率とワクチン有効性を詳細に記載。RSVpreFワクチンは60歳以上の成人において、RSV関連呼吸器疾患による入院を有意に減少させた。全呼吸器疾患や心肺疾患入院についても抑制効果が確認され、安全性にも大きな懸念はなかった。本試験は、RSVワクチンの高齢者での公衆衛生上の有用性を支持するものである。方法結果図表からの補足結論
2025-09-0922 min
A WonderCare PodcastRSV Immunisation Catch up Programme!RSV Immunisation Update: Inclusion of Catchup Cohort and New DevelopmentsIn this episode, Sheena explains the recent updates on the RSV immunisation program in Ireland. Last year, the monoclonal antibody called Nirsevimab was offered to babies born between September 1st and February 28th, providing protection against the respiratory syncytial virus (RSV). This year, the program has expanded to include a catchup cohort of babies born from March 1st to August 31st, addressing concerns from parents whose babies missed out previously. Sheena highlights the significance of this development, the benefits of the immunisation, and the impact on...
2025-08-2415 minくつ王レディオ高齢者におけるRSV入院と心血管イベントリスクの増加 Journal of the American Geriatrics SocietyRespiratory Syncytial Virus (RSV)-Related Hospitalization and Increased Rate of Cardiovascular Events in Older AdultsCitationJ Am Geriatr Soc, doi:10.1111/jgs.19591 (2025年)論文の要約本後ろ向きコホート研究は、カナダ・オンタリオ州における65歳以上の成人を対象に、RSV入院とその後の心血管イベント発生率との関連を評価したものである。対象・方法：2011年から2020年にRSV、インフルエンザ、尿路感染症、骨折で入院した高齢者を比較対象群とし、退院後最大1年以内の心不全、心筋梗塞、脳卒中、心房細動などの発生を追跡した。主な結果：RSV入院患者の18.5％が退院後に心血管イベントを経験し、これはインフル群（17.7％）、尿路感染群（12.1％）、骨折群（8.4％）に比べ有意に高かった。特に心不全の発生は、他群と比較して1.5〜3.7倍のリスク上昇と関連した（共変量調整後 HR）。副次的リスク：RSV患者は ICU 転送、延長入院、30日死亡率のいずれも他群に比して高リスクであった。臨床的意義：RSV感染は高齢者において短期・中期ともに心血管マルチモービディティの増大につながる可能性が示されており、RSVワクチン接種推奨だけでなく、退院後の心血管症状のフォローアップも重要とされる。本研究は、RSV感染による診療負担および長期的健康被害の理解を深め、高齢者医療における予防策とモニタリング設計を再考する上で非常に示唆に富む内容です。
2025-08-1507 min
'n Ma & 'n MikrofoonRSV, Varkgriep & Hand-Voet-en-Mondsiekte: Wat Jy Moet Weet/ RSV, Swine Flu & Hand, Foot and Mouth Disease – What You Need to KnowDis die drie siektes wat jou kind nou blykbaar om elke hoek en draai kan aansteek: hand-voet-en-mondsiekte, RSV en varkgriep.
In hierdie episode gesels Daniëlla met kinderdokter dr. Marlé van der Merwe oor hoe ouers dié virusse vinnig kan herken, hoe dit versprei, en wanneer jy regtig moet bekommerd wees.
Wat jy in dié episode gaan hoor:
*Wanneer is griep net griep – en wanneer is dit varkgriep?
*Waarom RSV só gevaarlik vir babas kan wees
*Is die nuwe RSV-inenting veilig?
*Wat jy regtig moet weet oor hand-, voet- en mondsiekte
*Waarom antibiotika nie die antwoord op alles is nie
*Waarom...
2025-07-0946 min
Going anti-ViralHow Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP – Dr Yvonne MaldonadoIn episode 50 of Going anti-Viral, Dr Yvonne Maldonado joins host Dr Michael Saag to discuss the respiratory syncytial virus (RSV) vaccine and the vaccine approval process in the United States. Dr Maldonado is a Professor in the Stanford University School of Medicine where she has achieved national and international recognition for her scholarship in the epidemiology and control of infectious diseases. She has served on several national and international committees including, until recently, the CDC Advisory Committee on Immunization Practices (ACIP). Dr Maldonado and Dr Saag provide an overview of RSV including the history of RSV vaccine research and...
2025-06-1735 min
Decera Clinical Education Infectious Disease PodcastListen Up: Time to Prioritize RSV Vaccination for AdultsRespiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions.In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.Listen as they discuss:The Burden of Adult RSVRSV Vaccines for Adults: Data and RecommendationsRSV Vaccine UptakePractical Strategies to Increase RSV Vaccine Uptake Faculty:Dr. Ruth Carrico is a family nurse pr...
2025-06-111h 06
Decera Clinical Education APP PodcastListen Up: Time to Prioritize RSV Vaccination for AdultsRespiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions.In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.Listen as they discuss:The Burden of Adult RSVRSV Vaccines for Adults: Data and RecommendationsRSV Vaccine UptakePractical Strategies to Increase RSV Vaccine UptakeFaculty:Dr. Ruth Carrico is a family nurse practitioner a...
2025-06-111h 06
Decera Clinical Education Infectious Disease PodcastThe Latest Data and Guidelines for Adult RSV VaccinesListen in as Carolyn Bridges, MD, FACP, reviews the estimated burden of respiratory syncytial virus (RSV) disease in older adults and discusses the latest updates on RSV vaccination recommendations and safety data. Topics covered include: Rates of RSV hospitalizations and emergency department visitsRSV vaccine developmentFDA-approved RSV vaccinesVaccine safety data: rates of atrial fibrillation and Guillain-Barré syndromeACIP RSV vaccine recommendationsRisk factors for severe RSV diseaseRSV vaccine uptakePresenter:Carolyn Bridges, MD, FACPConsulting Physician and Director of Adult ImmunizationsImmunize.orgSt Paul, MinnesotaLink to full program:https://bit.ly/4mH...
2025-06-0212 min
Pass the MSRA: Free PodcastsInf: Respiratory Syncytial Virus (RSV): Free MSRA Podcast⚕️ FREE MSRA PODCAST – Respiratory Syncytial Virus (RSV)🎯 In today’s Deep Dive, we break down Respiratory Syncytial Virus (RSV) into high-yield, exam-ready notes perfect for your MSRA revision.✅ Fast recall ✅ Clinical pearls ✅ Mnemonics ✅ Exam gold!🧠 Key Learning Points📌 Definition• RSV = common respiratory paramyxovirus• Causes mild illness in most but serious disease in infants, elderly, and immunocompromised💡 Mnemonic: "RSV = Really Serious in Vulnerable"📌 Transmission & Risk Factors• Spread via droplets, direct contact, contaminated surfaces• Peak infections: winter & early spring ❄️• High risk:Premature infantsDaycare exposure 🏫Smoke exposure 🚬...
2025-05-3006 min
漁業廣播電臺【消費追追追】RSV-你應該知道的預防和保護措施呼吸道融合病毒（Respiratory Syncytial Virus，RSV）是一種有高度傳染性的病毒，會影響呼吸道系統，尤其容易造成嬰幼兒與老年人的感染。許多人容易將RSV與流感或新冠病毒混淆。 RSV的症狀與這些病毒相似，但影響的族群與併發症有所不同。如何區別RSV病毒?可檢測方法來確診是否感染RSV?認識RSV的症狀與可能併發症說明。常見的RSV的傳播方式與感染特性說明。RSV的潛伏期?RSV可感染所有年齡層，但其影響程度會因年齡與健康狀況不同而有所差異?RSV有效的預防會建議施打疫苗，只是要擔心那些不良反應與可能的那些重大副作用?疫苗接種時宜注意事項?建議施打疫苗對象說明。日常生活中如何降低感染風險？
--
Hosting provided by SoundOn
2025-05-2117 min
Rio Bravo qWeekEpisode 188: RSV Management and PreventionEpisode 188: RSV Management and PreventionDr. Sandhu and future Dr. Mohamed summarize the management of RSV and describe how to prevent it with chemoprophylaxis and vaccines. Dr Arreaza adds some comments about RSV vaccines.Written by Abdolhakim Mohamed, MSIV, Ross University School of Medicine. Comments by Ranbir Sandhu, MD, and Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare...
2025-04-1115 minDr. Howard Smith ReportsA Longer-Lasting RSV VaccineVidcast: https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. This the result of a phase 3 so-called RENOIR trial that tested 36,862 participants 60 to over 80 years of age at 241 sites in 7 countries. Helmed by University of Rochester infectious disease researchers, it was just reported in the Clinical Infectious Diseases journal.The vaccine, developed by Pfizer, contains both RSV-A and RSV-B antigens. Tested against a placebo, the vaccine provided 88.9% prot...
2025-04-0201 min
Talking All Things CardiopulmEpisode 96: RSV is it Droplet? or Contact? or Both?As the winter season comes to an end, we review 1 of the 4 major viruses that has been rampant this year. Though RSV is officially on the decline, it is still very present in our communities and hospitals. Join us as we discuss virus transmission and possible precautions, that you may say in your setting. Is it Droplet or is it Contact? That seems to be a question these days and there seems to be some unclear writing on the wall. So let’s break it down. In this episode:Discuss pathophysiology of RSVTransmission of RSVCurren...
2025-02-2630 min
The PedsDocTalk Podcast: Child Health, Development & Parenting—From a Pediatrician MomHelp Reduce Risk of Serious RSV Lung Infection for Your BabyDid you know while hospitalization is uncommon, respiratory syncytial virus (RSV) is the leading cause of hospitalization for babies under 1? RSV season is typically fall – spring but can vary by local areas and today I'm sharing about a preventative antibody which can help protect against severe RSV lung infections. I'm joined by Shawn Johnson East and Dr. Natalie Barnett, Vice President of Clinical Research at Nanit, to discuss the importance of RSV protection for babies. They share personal experiences, including Shawn's family's journey with RSV, and offer expert insights on how parents can help protect their little ones during RS...
2024-12-1829 min
Pharmacy FriendsRSV: 'Tis the season for preventionDr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.
Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact...
2024-12-1725 min
A WonderCare PodcastRSV - Update - Is the Immunisation Working?!Understanding RSV and the Impact of NursivMab ImmunizationIn this week's episode, Sheena discusses Respiratory Syncytial Virus (RSV) and provides an update on the current RSV season. She explains the effects of Nirsevimab, the new RSV immunisation introduced through a Pathfinder program for babies born between September 1st and February 28th. She also reads a letter she wrote to Dr. Colm Henry and Minister Stephen Donnelly, urging them to extend the immunization to more babies. She provides insights into how RSV affects different age groups, the success of the Pathfinder program, and encourages listeners to advocate...
2024-12-1418 min
Your Checkup: Patient Education Health Podcast31: RSV Prevention for Infants: Nirsevimab & Maternal VaccineRespiratory syncytial virus (RSV) is a common respiratory virus that can be dangerous for infants. This episode of Your Checkup provides essential information about RSV, exploring new prevention methods like the monoclonal antibody nirsevimab and the maternal RSV vaccine. We discuss how they work, who should consider them, and their safety profiles. Tune in to learn how to safeguard your baby from this potentially serious virus.TakeawaysRSV is a common respiratory virus that can severely affect infants.Nersivimab is a new immunization option for RSV prevention.The immunization is effective in reducing hospitalizations...
2024-11-1124 min
SMFM's Podcast SeriesMaternal RSV Vaccination 101In this episode of the SMFM Podcast, Dr. Marwan Ma'ayeh discusses maternal RSV vaccination with Dr. Sarah Boudova, an expert in infectious diseases and a third-year maternal-fetal medicine fellow. They dive into the Abrysvo vaccine and explain its importance for protecting newborns from RSV-related respiratory illnesses. Dr. Boudova provides essential insights into the vaccine's components, its unique role during pregnancy, timing considerations, and co-administration with other vaccines. They also touch on current recommendations from leading health organizations and outline practical advice for healthcare providers on storing and administering the vaccine. Listen to learn how maternal RSV vaccination can safeguard...
2024-11-0421 min
The Oh Baybee! PodcastDo This To Protect Your Baby From RSVSend us a textEp 42:Welcome, mama! Today, we’re covering an essential topic to help you protect your newborn from RSV. RSV, or respiratory syncytial virus, can cause serious respiratory issues in infants. The good news? Breastfeeding can be a natural defense!In this episode, we cover:What RSV is: Understanding the virus and why it can pose a risk to babies, especially those under six months.How Breastfeeding Helps: Discover how breast milk’s immune-boosting properties, like antibodies and white blood cells, protect agai...
2024-10-3105 min
The Medical Minute: Dr Anne and Dr MozThe Medical Minute - 2024 Episode 10 - Guardians of the Airways: RSV Immunisation UnveiledThis week, Dr Anne and Dr Moz discuss the RSV vaccine, covering immunisation for pregnant women and infants.
IMPORTANT LINKS:
Handbook on Maternal RSV Vaccination (Abrysvo):
https://immunisationhandbook.health.gov.au/recommendations/pregnant-women-are-recommended-to-receive-an-rsv-vaccine-during-pregnancy
Guide for which infants should receive the RSV jab (Beyfortus):
https://immunisationhandbook.health.gov.au/resources/figures/figure-flowchart-to-guide-which-infants-should-receive-nirsevimab-in-their-1st-rsv-season
Currently available information on the intended state-funded RSV infant immunisation program:
https://www.betterhealth.vic.gov.au/respiratory-syncytial-virus-rsv#2025-rsv-infant-immunisation-program
Follow The Medical Minute on Instagram:
https://www.instagram...
2024-10-1823 min
A WonderCare PodcastAn Honest Guide to the new RSV Immunisation!Comprehensive Guide to the New RSV Immunisation for ParentsIn this detailed episode, I provide an in-depth exploration of the new RSV immunisation, focusing on its importance, safety, and effectiveness. The discussion covers the basics and risks of Respiratory Syncytial Virus (RSV), the introduction and benefits of the Nirsevimab vaccine, and potential side effects. The episode compares Nirsevimab with the older Palivizumab, highlighting its superior efficacy in reducing hospitalisations and ICU admissions. It also addresses eligibility guidelines, the vaccination process, accessibility through government programs, and specific advice for parents, especially those with infants born from September 1...
2024-10-1829 min
VerifiedRxTake a Deep Breath: RSV Vaccinations InformationWe emerged from the COVID -19 pandemic in 2022 to headlines about unseasonably early spikes in respiratory syncytial virus and concerns and threats of a triple pandemic of CV19, influenza, and RSV. Fortunately, there’s been no triple pandemic, but what has emerged is multiple first-time vaccine approvals for RSV. Dr. John Schoen, Senior Manager of Drug Information at The Vizient Center for Phamacy Practice Excellence joins his colleague and Program Host Stacy Lauderdale, Associate Vice President of Evidence-Based Medicine to discuss the use of the RSV vaccines.
Guest speakers:
John Schoen, PharmD, BCPS
Senio...
2024-10-0821 min
WSPID PodcastFighting RSV with Maternal ImmunizationIn this episode of the WSPID Podcast, hosts Dr. Alicia Chang and Dr. Linny Phuong come together to discuss RSV and the developments surrounding maternal immunization and therapeutics.
Featuring an insightful interview with A/Prof Flor Muñoz, MD, MSc, who is an Associate Professor of Pediatrics, Infectious Diseases, Molecular Virology, and Microbiology at Baylor College of Medicine, and Director of Transplant Infectious Diseases at Texas Children’s Hospital in Houston, Texas.
This conversation highlights the need for global collaboration and resources to implement these preventative measures.
This episode was recorded in May 2024, and...
2024-09-1942 min
The Obs PodEpisode 175 RSV vaccineCurious about how the new RSV vaccine could protect your baby? Join me, Florence, as we uncover the latest addition to the UK’s maternal vaccination program. In this episode of the OBSpod, I break down everything you need to know about the respiratory syncytial virus (RSV) vaccine. Learn how this innovative recombinant vaccine works & why it's crucial for infants under a year old.Expectant mothers, healthcare professionals, and anyone interested in maternal and infant health will find this episode particularly enlightening. I'll guide you through the rationale behind the vaccine's introduction and its expected impact on bo...
2024-08-1018 min
IDA-Sprechstunde"Neue RSV-Impfstoffe: 12 tote Babys!" - IDA-Sprechstunde #35 von 24.07.2024"Neue RSV-Impfstoffe: 12 tote Babys!" - IDA-SPRECHSTUNDE mit Dr. Gunter Frank & Dr. Kay Klapproth:
"Neue RSV-Impfstoffe: 12 tote Babys!" vom 24.7.24
Themen:
Es gibt neue Impfstoffe gegen RSV, die nun allen Babys und Menschen über 60 Jahren verabreicht werden sollen.
Impfung für alle: Die STIKO empfiehlt nun eine RSV-Impfung für alle Neugeborenen. Dabei ist das Risiko durch RSV-Infektionen sehr ungleich verteilt, und die Wirksamkeit sowie die Sicherheit der neuen Impfstoffe sind durchaus fraglich.
Neuer mRNA-Impfstoff: Auch gegen RSV-Infektionen gibt es jetzt einen genbasierten Impfstoff. Moderna nutzt die gleiche Technologie wie für ihren...
2024-07-2443 min
Dr. Chapa’s OBGYN Clinical PearlsNew Data (July 8, 2024) for Maternal RSV VaccineRSV season is just around the corner (Fall and Winter months). Newborns are 16x more likely to be hospitalized with serious RSV lung infection than the flu. On August 21, 2023, the FDA approved the first RSV vaccine, Abrysvo, for use in pregnant individuals to protect newborns and infants against severe RSV disease in the first 6 months after birth. The FDA approved the vaccine to be administered between 32 and 36 weeks and 6 days of gestation. Then, on September 22, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend a single dose of maternal RSV vaccination for pregnant people at 32 through 36 we...
2024-07-0939 min
Impfen mit Sinn und Verstand#37 RSV-Immunisierung: 200 Mio EUR für 1% RisikoreduktionEine veränderte STIKO Empfehlung
“Buy“-fortus (Beyfortus®): ca. 200 Mio. Euro jährlich für ca. 1% absolute Risikoreduktion“ - Eine passive Immunisierung, die Sanofi und Astra Zeneca aktiv nützt.
Thema: Die neueste Stiko-Empfehlung zur Prophylaxe gegen RSV-Infektionen für alle Neugeborenen und Säuglinge.
In dieser Episode geht es also um die neue STIKO-Empfehlung zum Thema RSV - ein Update zur Episode 27 unseres Podcasts.
Im Einzelnen geht es um Fragen wie diese:
Warum passt die STIKO die Empfehlung für den RSV an?
Auf welcher wissenschaftlichen Grundlage fußt diese Empfehl...
2024-07-0528 min
A WonderCare PodcastDr Suzanne Crowe - Why the RSV Immunisation Programme for this Winter is not enoughDr. Suzanne Crowe, a pediatric intensivist, discusses her role in intensive care medicine and the impact of respiratory syncytial virus (RSV) on the health system. She emphasizes the need for vaccinating babies against RSV how crucial it is to expand the planned programme for this Winter. Dr. Crowe highlights the trauma that babies and their families experience when a baby is hospitalized with RSV and the strain it puts on healthcare resources. She calls for a more holistic approach to healthcare and the prioritization of children's health.Takeaways
2024-07-0331 min
'ne Dosis Wissen | Der Medizin-Podcast für Menschen im GesundheitswesenRSV-Schutz für Säuglinge: Antikörper oder Impfung der Mutter?
Eine RSV-Infektion kann für Neugeborene gefährlich werden. Eine RSV-Impfung von schwangeren Frauen schützt den Nachwuchs laut einem neuen Cochrane-Review gut vor Krankenhausaufenthalten im Zuge einer RSV-Infektion. In ihren neuen Empfehlungen spricht sich die STIKO jedoch nicht für eine solche Impfung aus. Sie setzt stattdessen auf eine passive Immunisierung mit einem Antikörper. Dr. Laura Weisenburger, Ärztin und wissenschaftliche Redakteurin bei der Apotheken Umschau, spricht über beide Ansätze.
Stand: 3. Juli 2024
Quellen und nützliche Links
Aktueller Cochrane-Review zur RSV-Impfung von schwangeren Frauen (engl.)
STIKO-Empfehlung zur RSV-Prophylaxe bei Säuglinge...
2024-07-0312 min
Medscape InDiscussion: Respiratory Syncytial Virus in AdultsWhen RSV Hits Home: Community Care in Rural West VirginiaJoin Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982 CDC RSV Surveillance and Research...
2024-06-0421 min
Decera Clinical Education Infectious Disease PodcastUnderstanding Risk Factors for Severe RSV DiseaseIn this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including:RSV seasonality and disease burdenSymptoms and complications of RSV infectionOlder age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization)Comorbidities associated with increased risk of RSV hospitalizationRSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses Faculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkContent based on a CME p...
2024-05-0714 min
Mobidoctor PodcastShould You Get The New RSV Vaccine?Should you get the new RSV vaccine — and who is eligible in Europe?Respiratory Syncytial Virus (RSV) can cause serious lower respiratory infections, particularly in older adults and vulnerable groups. In this episode, we explain how the new RSV vaccines work, current eligibility guidance in Europe, and when vaccination may be recommended.You’ll learn:• What RSV is and how it affects the lungs and airways• Who is at higher risk: adults over 60, people with chronic heart or lung disease, and immunocompromised individuals• How the RS...
2024-05-0312 min
Mobidoctor PodcastRSV When It's More Than Just A Cold - RSV In ChildrenWhen is RSV more than just a cold — and how serious is RSV in children?Respiratory Syncytial Virus (RSV) is a common viral infection, but in infants and young children it can lead to bronchiolitis or pneumonia. In this episode, we explain how RSV presents in children, which symptoms require urgent assessment, and current clinical guidance in Europe.You’ll learn:• What RSV is and how it spreads through respiratory droplets and close contact• Early symptoms: runny nose, cough, mild fever, reduced appetite• Signs of b...
2024-05-0308 min
Mobidoctor PodcastRSV Respiratory Syncytial VirusWhat is RSV (Respiratory Syncytial Virus) — and when can it become serious?RSV is a highly contagious respiratory virus that affects the lungs and airways. While many cases resemble a common cold, RSV can cause bronchiolitis or pneumonia in infants, older adults, and vulnerable individuals. In this episode, we explain symptoms, risk factors, and when medical assessment is needed in Europe.You’ll learn:• How RSV spreads through respiratory droplets and surface contact• Typical symptoms: runny nose, cough, fever, wheezing, and fatigue• Why infants, o...
2024-05-0312 min
Cocooned HealthEp 6. RSV Ready: New Mumma Vaccine and Antibody Breakthroughs. Expert Guest: Professor Paul HeathEpisode 6. RSV Ready: New Mumma Vaccine and Antibody Breakthroughs. Expert Guest: Professor Paul Heath
Paul Heath is a Professor and Honorary Consultant in Paediatric Infectious Diseases at St George's University Hospitals NHS Foundation Trust and St George’s, University of London, where he is the Director of the Vaccine Institute.
His research interests include the epidemiology of vaccine preventable diseases, and clinical vaccine trials, particularly in at-risk groups and in perinatal infections. He coordinates the UK Paediatric Vaccine Group (UKPVG), is a member of the JCVI, is the NIHR Speciality Lead for Children’s research for...
2024-04-1532 min
The Skeptics Guide to Emergency MedicineSGEM #435: Don’t Stop Believing…A Vaccine can Work for RSVReference: Drysdale SB et al. Nirsevimab for Prevention of Hospitalizations due to RSV in Infants. N Engl J Med. 2023
Date: March 29, 2024
Guest Skeptic: Dr. Michael Cosimini is a pediatrician in Portland Oregon. He is the designer of Empiric Game, a medical editor and contributor to Pediatrics Reviews and Perspectives (PedsRAP) and the digital media editor at Academic Pediatrics. He is passionate about podcasting and serious games for medical education.
Dr. Michael Cosimini
Case: A 4-month-old twin girl is brought by her parents to the emergency department (ED) for respiratory distress. She has had congestion, a runny nose, and a cough f...
2024-04-0627 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRSV and Healthcare Facilities: Preventing Outbreaks and Minimizing Transmission With Education, Testing, and CohortingJoin Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998282). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index...
2024-04-0319 min
POMA DOes...RSV and Influenza: Pediatric Patients and Pregnant MothersEpisode Summary: Despite a multiyear pandemic and availability of vaccines to decrease the impact of severe respiratory viral infections, such as RSV and Influenza, thousands of patients are hospitalized every year. Additionally, healthcare professionals and the general public have not achieved a satisfactory immunization rate for these infections. In today's episode we sit down with a pediatrician and an obstetrician to discuss RSV and Influenza in pregnant and pediatric patients, the risks of severe infection, and available vaccines and treatment options. Key Takeaways: RSV and Influenza are common, highly contagious viruses t...
2024-03-0822 min
Inside Family MedicineDr. LaTasha Seliby Perkins: A Maternal RSV Vaccination DiscussionHear from family physician LaTasha Seliby Perkins, MD, FAAFP, on maternal RSV vaccination guidelines and recommendations and ways to overcome vaccine hesitancy. Vaccines newly available in the 2023-2024 respiratory season are presenting new opportunities to protect against RSV, but vaccine hesitancy continues to present challenges in increasing vaccination rates for flu, COVID-19 and RSV. Dr. Seliby-Perkins outlines the responsibility of family doctors in educating their most vulnerable patients about these vaccines and clarifying any concerns among them and offers concrete tips for overcoming vaccine hesitancy. Learn more from the AAFP about vaccines for COVID-19 and...
2024-03-0718 minPOMA DOes...RSV and Influenza: Older Adults and Immunocompromised PatientsEpisode Summary: Despite a multiyear pandemic and availability of vaccines to decrease the impact of severe respiratory viral infections, such as RSV and Influenza, thousands of patients are hospitalized every year. Additionally, healthcare professionals and the general public have not achieved a satisfactory immunization rate for these infections. In today's episode we sit down with a pulmonologist and a hospitalist to discuss RSV and Influenza, at-risk patient populations, the risks of severe infection, and available vaccines and treatment options. Key Takeaways: The CDC estimates there have been at least 20 million illnesses f...
2024-02-0951 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRisk Factors and Complications of RSV in AdultsJoin Drs Forest Arnold and Edward Walsh as they discuss risk factors and complications of RSV in adults. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998278). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources RSV Surveillance & Research https://www.cdc.gov/rsv/research/index.html Respiratory Viral Infections in the Elderly https://pubmed.ncbi.nlm.nih.gov/33749408/ Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins...
2024-02-0118 min
PaidiatrosmouRSV ιόςΓεια σας και καλωσηρθατε στο δεύτερο επεισόδιο του ποντκαστ Paidiatrosmou. Είμαι ο Στράτος και σήμερα θα μιλήσουμε για τον RSV ή αλλιώς αναπνευστικό συγκυτιακό ιό. Συγκεκριμένα θα απαντήσουμε στα ερωτήματα: Τι προκαλεί αυτός ο ιος και ποια τα χαρακτηριστικά του; Ποια παιδάκια κινδυνεύουν περισσότερο; Ποια είναι τα συμπτώματα και ποια η θεραπεία και πολλά άλλα.
Περιεχόμενο:
0:55 Τι είναι ο RSV ιός;
1:25 Ποια τα συμπτώματα;
03:35 Γιατί τους τελευταίους 2 χειμώνες παρατηρήσαμε τόσα πολλά και σοβαρά κρούσματα;
04:53 Περνάνε όλα τα παιδιά τον RSV;
05:55 Ποια τα χαρακτηριστικά του RSV ιού;
06:30 Πώς μεταδίδεται ο ιός;
07:58 Γίνεται να περάσουμε τον ιό πάνω από μια φορά;
08:48 Πότε εμφανίζονται τα πρώτα συμπτώματα;
10:05 Πώς θα καταλάβετε αν το παιδί έχει προσβληθεί από RSV;
11:00 Ποια παιδιά κινδυνεύουν περισσότερο;
11:42 Τι πρέπει να προσέχετε στο σπίτι;
14:28 Ποια η θεραπεία;
17:20 Σύνοψη θεραπείας.
18:10 Υπάρχουν μακροχρόνιες επιπτώσεις μετά από λοίμωξη με RSV ιό;
20:04 Μέτρα πρόληψης.
22:08 Σύνοψη και take home messages.
2024-01-1723 min
Decera Clinical Education Infectious Disease PodcastRSV Vaccines in Adults: A Risk-Based ApproachIn this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendationsRisk factors associated with severe RSV disease, including RSV-related hospitalizationsApproach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities Health disparities related to RSV vaccinesConsiderations for a risk-based approach, rather than age alone, to determine vaccine candidacy Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious Diseases...
2023-12-2709 minVerifiedRxRollout Strategy Vexing: Pediatric RSV prevention strategy implementation challengesRSV infections are not new and have devastating impacts. The recent advent of new prevention strategies has renewed the focus on the disease with a hopeful outlook. For the last 25 years, the only FDA approved product preventing RSV, lower respiratory tract disease, was palivizumab or Synagis, a monoclonal antibody indicated for use in high risk infants children and administered intramuscularly monthly throughout the RSV season.
In May, the first ever RSV vaccines were approved, Arexvy and Abrysvo. These two new RSV vaccines were approved for use in adults greater than or equal to 60 years of age. In...
2023-12-2625 min
Docs2Dads - A Pediatrician’s Field Guide for Fathers100. Protecting Your Baby from RSVJoin me, Dr. Scott Grant, on the next Docs2Dads episode as I welcome a special guest, Dr. Herb Bravo from "The Pediatric Lounge" podcast. We delve into the critical topic of protecting our little ones from Respiratory Syncytial Virus (RSV) during the upcoming winter season. You can find Dr. Bravo's interview with Dr. Paul Offit here. In this informative and engaging episode:Exploring the RSV LandscapeUnderstand the prevalence and impact of RSV on infants.Dr. Herb Bravo and I share insights into why RSV protection is crucial for the tiniest m...
2023-12-1457 min
Kid Doc — Good Job Being the Mom!RSV--Bad Boy Respiratory VirusRSV episodeWE ARE DOING THIS EPISODE AT THE START OF COLD AND FLU SEASON. WE THOUGHT IT WOULD BE TIMELY TO TALK ABOUT RSV.What is RSV?Why does it have such a bad reputation compared to other colds?RSV isn’t just a disease for children but we mostly hear about it in children. Should we be testing for this more in adults?
2023-12-0315 min
Decera Clinical Education Infectious Disease PodcastReady, Set, Vaccinate! RSV Vaccination for Older AdultsIn this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: Breakthroughs in RSV vaccine developmentRSV vaccine snapshot in older adultsFDA-approved RSV vaccines for older adultsCDC evidence to recommendations framework for vaccinesRSV burden in older populationsBenefits and harms of RSV vaccinationRSV vaccine efficacy and safety in older adultsCDC Advisory Committee Immunization Practices recommendations for RSV vaccines in older adultsPopulations at high risk for severe RSV diseaseVaccination considerations based on the upcoming RSV seasonFaculty:Richard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology University of...
2023-11-3016 min
Decera Clinical Education Infectious Disease PodcastA Difficult Differential: Clinical Presentation and Diagnosis of RSV in AdultsIn this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Richard Zimmerman, MD, MPH, FAAFP, discuss the clinical presentation of RSV in older adults and available diagnostic tests for RSV, including: Comparison of RSV clinical symptoms to influenza and COVID-19, including differentiating symptoms at infection onsetRSV disease progression RSV diagnostic approaches How RSV diagnosis of adults may differ from diagnosis of childrenClinical considerations for RSV testingHow to improve RSV awareness among patientsProgram Director:Pamela Rockwell, DO, FAAFPProfessorFamily MedicineUniversity of Michigan Medical SchoolAnn Arbor, MichiganF...
2023-11-3008 min
Decera Clinical Education Infectious Disease PodcastA Hidden Annual Epidemic: The Burden of RSV in AdultsIn this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Rick Zimmerman, MD, MPH, FAAFP, discuss the burden of RSV in older adults, including:RSV burden throughout lifeRSV seasonality in the United StatesComparative burden and incidence of RSV and influenza in adults aged 65 years or olderCardiopulmonary hospitalizations of long-term care facility residents with influenza and/or RSVRisk factors for severe RSV (eg, hospitalization, mortality) in older adultsRSV incidence by presence of underlying medical conditionsRSV awareness among healthcare professionals and patients Program Director:Pamela Rockwell, DO, FAAFPProfessorFamily MedicineU...
2023-11-2912 min
True BirthRSV Vaccine in Pregnancy: Episode #143Respiratory syncytial virus (RSV) is a common virus that can cause respiratory infections in people of all ages, including pregnant women. RSV infections are more prevalent during the fall and winter months. While RSV infections are usually mild and cold-like in healthy adults, they can lead to more severe respiratory symptoms in certain populations, including young infants and individuals with weakened immune systems. In the context of pregnancy, RSV infections are generally considered a concern primarily because of the potential impact on the health of the mother and the developing fetus. Here are some key points to...
2023-11-2125 min
Charting PediatricsRemarkable RSV Vaccines: Is This the End of the RSV Burden As We Know It? Respiratory Syncytial Virus (RSV) is one of the most common causes of childhood respiratory illness, resulting in annual outbreaks among all age groups. In the United States, an estimated 60,000 to 80,000 children, the majority of whom are under 6 months of age, are hospitalized each year. Approximately 100 to 300 kids die from this infection each year. RSV is the single most common cause of death from respiratory illness, after the newborn period, in developing countries. This year, the medical community has made history with the first RSV vaccine approvals for pregnant individuals, infants and the elderly. In this episode, we are taking...
2023-11-2140 min
IMA (Formerly FLCCC Alliance)KC#010 RSV Vaccine: Kid's Corner with Dr. Liz
In this episode of ‘Kid’s Corner', pediatrician Dr. Elizabeth Mumper discusses the RSV vaccine and covers important questions like:
• Should you get the RSV vaccine if you are elderly or pregnant?• How common is RSV in babies?• How dangerous is RSV in children?
RSV is a routine illness that the overwhelming majority of babies can handle. By the age of 2, 97% of children have been infected with RSV. Of these, each year, the CDC tracks around 17 deaths. Based on these numbers, does it make sense to mass vaccinate babies for RSV? Learn more...
2023-11-1719 min
20-Minute Health TalkCovid, flu, RSV: What vaccines do I need this fall/winter?While the flu shot has been around since 1945, 2023 marked the introduction of a new vaccine for respiratory syncytial virus (RSV) — the first ever — and the latest Covid-19 shot. The Food and Drug Administration recently approved the two new vaccines, and the protection they offer comes just in the nick of time: Health officials say there is a strong likelihood of another "tripledemic" this winter. In addition to the vaccines for Covid, flu and RSV, there is a new protective treatment for RSV — a potentially life-saving option for those most at risk of complications. On this episode, family medicine doctor Eric As...
2023-11-0217 min
Academia VRS7. Lagunas y dudas sobre el conocimiento del RSVGaps and doubts about RSV knowledge
Prof. Harish Nair
Professor of Paediatric Infectious Diseases and Global Health, Co-Head of Centre for Global Health
University of Edinburgh
Scotland, UK
Welcome to a new episode of the RSV ACADEMY podcast, where explore the ever-evolving world of Respiratory Syncytial Virus (RSV). In this episode, we are honored to have Professor Harish Nair, a leading epidemiologist based at the University of Edinburgh, as our guest. With a career dedicated to understanding the epidemiology, burden, and prevention of RSV, Professor Nair's work has been instrumental in shaping global health policies. He has led several...
2023-10-3040 min
Homeopathy for MommiesHomeopathic Remedies for RSV SymptomsRSV is a common virus that primarily affects the lungs and respiratory tract, causing symptoms similar to a common cold. Most children contract this virus by the age of two, and while the symptoms are usually mild, it can cause severe infections in premature babies, infants, and individuals with weakened immune systems or underlying lung or heart issues.
There are various homeopathic remedies that can be helpful for respiratory issues, particularly in cases of exposure to toxins, viruses, bacteria, or flu. Aconite, Antimonium Tartaricum, Carbo Veg, Arsenicum Album, Baptisia, Belladonna, Bromium, Bryonia, and Chamomilla are some of...
2023-09-1933 min
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast171 - Two Vax's and a MAB: What's New in RSV PreventionIn this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines (Abrysvo and Arvexy) in preventing RSV infections in older adults and in pregnant women. Key Concepts RSV is a contagious respiratory virus that is usually mild and self-limiting in most patients but can cause severe disease especially in young children or older adults with certain risk factors. The FDA recently approved two vaccines for RSV (Abrysvo from Pfizer and Arexvy from GSK). The initial FDA approval was for adults 60 years of age...
2023-09-1942 min
LungcastRSV Wrap-up: Transmission, Testing & Timing of Vaccinations with Dr. Barbara TaylorWith cases of Respiratory Syncytial Virus (RSV) on the rise this fall, Dr. Barbara Taylor, professor of infectious diseases at UT Health San Antonio, joins us for this timely episode all about RSV. Importantly, she covers the unprecedented events of the 2022-2023 season that was marred by a ‘tripledemic’ of respiratory diseases. How do the lessons learned change the preventive approach to better protect against the deadly infection? Episode Highlights0:16 Intro0:48 The burden of RSV today2:11 Transmission, presentation and diagnosis of RSV4:33 Likelihood of an RSV, COVID-19, flu “triple-demic”7:35 The history of RSV vaccin...
2023-09-1838 minImpfen mit Sinn und Verstand#27 Das Respiratorische Synzytial Virus – RSVRSV, Impfung, Meldepflicht: Besteht Handlungsbedarf? Wenn ja: welcher?
In dieser Episode beschäftigen wir uns mit dem Respiratorischen Synzytial-Virus, besser bekannt als RSV:
Der Anlass: Die nächste RSV-Saison steht vor der Tür und im Sommer wurde die Meldepflicht für RSV beschlossen.
Was ist RSV und wie wurde es gefunden?
Wer bekommt RSV: Die meisten nehmen es als normalen Schnupfen wahr.
Welche Risikofaktoren gibt es, welche Komplikationen treten auf bezüglich der Atmung, vor allem bei Säuglingen?
Wie ist die Lage bei älteren Kindern und Erwachsenen?
Gibt es eine wirksame RSV-Impfung? Wie hat sich Corona auf RSV...
2023-09-0829 min
英语每日一听 | 每天少于5分钟第1892期:New RSV Vaccine Approved for ChildrenU.S. officials on Monday approved the first long-acting drug to protect babies and young children against respiratory syncytial virus, or RSV. RSV sends tens of thousands of American children to the hospital each year. The virus is a cold-like disease for most healthy people. But it can be life-threatening in the very young and very old. Last year, a large increase in RSV cases crowded U.S. hospitals with sick children. The Food and Drug Administration (FDA) approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.美国官员周一批准了第一种长效药物，用于保护婴儿和幼儿免受呼吸道合胞病毒（RSV）的侵害。RSV 每年将数万名美国儿童送往医院。 对于大多数健康人来说，该病毒是一种类似感冒的疾病。 但对于年幼和年老的人来说，它可能会危及生命。 去年，呼吸道合胞病毒病例大幅增...
2023-07-2403 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsBreakthrough: RSV Therapies in the PipelineTreatment therapies for adults with RSV have been elusive, but there are promising breakthroughs on the horizon. Join Drs Forest Arnold and Richard Plemper as they discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985980). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Cell Entry of Enveloped Viruses https://pubmed.ncbi.nlm.nih.gov/21927634/ Product Review on the Monoclonal Antibody Palivizumab for Prevention of Respiratory Syncytial Virus Infection...
2023-07-1222 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRSV Infections in Patients Receiving Bone Marrow TransplantRSV infection before or after bone marrow transplantation or CAR T-cell therapy can be challenging to manage. Tune in to hear experts Drs Forest Arnold and Melody Smith discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985979). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview Hematopoietic Stem Cell Transplantation (HSCT) https://emedicine.medscape.com/article/208954-overview ...
2023-06-1418 min
'ne Dosis Wissen | Der Medizin-Podcast für Menschen im GesundheitswesenNeuer Impfstoff: Für wen sich eine RSV-Impfung lohntDer erste Impfstoff gegen RSV steht vor der Zulassung in Europa
Eine Infektion mit dem RS-Virus ist nicht für alle Menschen harmlos. Nun steht der erste Impfstoff vor der Zulassung. Dr. Laura Weisenburger, Ärztin und wissenschaftliche Redakteurin bei der Apotheken Umschau, schaut sich die Wirksamkeit an und erklärt, für wen eine Impfung sinnvoll ist.
Quellen und nützliche Links:
Erste Ergebnisse der Phase-3-Studie zum neuen RSV-Impfstoff von GSK (engl.)
Erste Ergebnisse der Phase-3-Studie zum neuen RSV-Impfstoff von Pfizer (engl)
FDA. Pressemitteilung zur Zulassung des ersten RSV-Impfstoffs:
https...
2023-05-2509 minMedscape InDiscussion: Respiratory Syncytial Virus in AdultsRSV Trends After COVID-19: Back With a VengeanceJoin Drs Forest Arnold and Victoria Statler as they discuss RSV after the COVID-19 pandemic. Tune in to hear about an increase in hospitalization rates, surprising seasonal shifts, and more. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985977). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources CDC RSV National Trends https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html RSV-NET https://www.cdc.gov/rsv/research/rsv-net/overview-methods...
2023-05-1019 min
CEimpact PodcastThe Novel RSV Vaccine: Part 2Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 2 of a two-part series examining new research on the proposed RSV vaccine. The GameChangerRSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in pregnant patients may help newborns. Sh...
2023-05-0831 min
CEimpact PodcastThe Novel RSV Vaccine: Part 1Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 1 of a two-part series examining new research on the proposed RSV vaccine.The GameChangerRSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in older adults improves antibody titers. ...
2023-05-0129 min
Decera Clinical Education Infectious Disease PodcastRSV in Adults: A Hidden EpidemicIn this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the impact of respiratory syncytial virus (RSV) and describe those at risk for severe RSV disease, including: RSV prevalence and seasonality RSV burden throughout life, including burden in older adultsComorbidities that increase the risk of RSV complications RSV transmission in the hospital and care home settingImplications of risk factors for severe RSV on prevention and treatment Faculty: Angela Branche, MDAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkH...
2023-03-2210 min
NeoChatsNeoChats - Series 7 | Episode 1: Common Questions Parents have about RSV Prophylaxis - Fiona GuyNeoChats - Series 7 | Episode 1: Common Questions Parents have about RSV ProphylaxisFiona Guy BSc., BScN, RNRSV Clinic Coordinator McMaster Children’s HospitalHamilton, OntarioBiography: Fiona Guy is the RSV Clinic Coordinator at McMaster Children’s Hospital and Senior Administrator for the RSV Data Management System at Mount Sinai Hospital. She has a Bachelor of Science and a Bachelor of Science in Nursing from the University of Western Ontario. Fiona’s expertise is in Neonatal Nursing as she worked in the Neonatal Intensive Care Unit at both North Y...
2023-03-1018 min
High-Fidelity Conversations'Tis the Season for RSV | Pediatric RSV management with Laura Holdren[Ep10] Do you work in EMS or another kind of healthcare space where you primarily see adult patients? Maybe pediatric patients aren't your specialty, but there's still a chance you might encounter one when you clock-in for your shift? Let's chat about what to keep in mind when taking care of pediatric patients who may have RSV - and more - on this episode of High-Fidelity Conversations! Laura Holdren, MSN, RN is an EMS Coordinator with the Nationwide Children's Hospital EMS Program, here in Columbus, Ohio. She also functions as a nurse educator/EMS CE instructor. F...
2023-02-0634 min
PodcastDXRSV /Respiratory syncytial virusThis week we will discuss another respiratory virus that has been really hitting hard here in the United States this season. Respiratory syncytial virus (RSV) is a contagious virus that is usually mild, but can severely affect the lungs and respiratory airways in older adults While you may not have heard of it yet, RSV is not a new virus and may be more of a health concern than you think—even if you're healthy. And if you're aged 60 or older, you can get RSV. But don't worry, by coming here you've taken a sa...
2023-01-0318 min
PodcastDXRSV /Respiratory syncytial virusThis week we will discuss another respiratory virus that has been really hitting hard here in the United States this season.
Respiratory syncytial virus (RSV) is a contagious virus that is usually mild, but can severely affect the lungs and respiratory airways in older adults While you may not have heard of it yet, RSV is not a new virus and may be more of a health concern than you think—even if you're healthy. And if you're aged 60 or older, you can get RSV.
But don’t worry, by coming here you’ve taken a...
2023-01-0318 min
Hand, Fuß, MundRSV-Infektion: Darum kann sie so gefährlich werden (Wdh)Eine RSV-Welle überrollt Deutschland 2022
👉 GIB UNS DEINE STIMME FÜR DEN DEUTSCHEN PODCASTPREIS 🗳️
Unser Buch 📚 HIGH FIVE - Die 5 Säulen einer gesunden und glücklichen Kindheit - ab 16.02.2023 - jetzt bestellen:
Hardcover: Amazon | Bücher.de | Thalia
Ebook: Hugendubel | eBook.de
… und natürlich in jedem Buchhandel deines Vertrauens!
Aktuell überrollt eine RSV-Welle Deutschland und bringt Kinderkliniken an ihre Belastungsgrenzen. Aufgrund der Relevanz des Themas strahlen wir diese Episode aus September 2021 ein weiteres Mal aus.
Was sind RSV und wie machen sie Kinder krank? Was ist eine Bronchiolitis und können RSV auch andere Teile der...
2022-12-2939 min
The Alvin Galloway ShowThe Alvin Gallwoay Show (TAGS) -"The Alarming Surge of Pediatric RSV.--How Can We Keep Our Young Children Safe?” 11-27-2022The Alvin Galloway Show, (TAGS), 2 p.m. to 4 p.m. (MST), on listen2krdp.com (Indie) and KRDP 90.7 FM in the East Valley.
This segment of TAGS; In this country we are in the grasps of a possible “tridemic set of viruses,” the flu, COVID and RSV. a press briefing hosted by Ethnic Media Services this segment is: "The Alarming Surge of Pediatric RSV.--How Can We Keep Our Young Children Safe?”
A new study estimates that 1 in 50 deaths of otherwise healthy children under age 5 around the world is due to a common virus that’s curren...
2022-12-121h 14
中旺雲中旺速遞 ｜嬰幼兒家長需注意 RSV病毒提前爆發 2022 11 21呼吸道合胞體病毒（RSV），是一種可導致嬰兒呼吸困難的病毒，該病毒在近日開始爆發，令加州的一些大型兒童醫院進入緊張狀態。 專家認為，這種病毒通常冬季爆發，現在提前爆發顯得非比尋常，有嬰幼兒的家長應做好防護。 除了RSV之外，其它呼吸道疾病，包括流感和covid病毒感染人數也在增加。 CDC官員們尚不清楚今年為何比往年提前有更多RSV病例。
洛杉磯兒童醫院首席醫療官在一份聲明中表示，RSV以及其它呼吸道疾病讓他們的急診室難以應付，他們一直試圖盡力接受從其它地方轉診過來的呼吸道患者，但因為受急診室容量限制，難以繼續接收患者。 不僅在洛杉磯，在聖地牙哥也是如此。 據CBS8報導，在聖地牙哥拉迪兒童醫院。 過去幾周有近400名兒童RSV檢測呈陽性。 再加上其它病毒患者，導致患者在急診室要等待很長時間。
在北加州奧克蘭醫院的急診科也是人滿為患。 加州大學三藩市貝尼奧夫分校的兒科住院醫師表示，RSV和呼吸道疾病的爆發，已導致醫院容量不足，病人們需在急診室等待床位。
而在南加州的橙縣，兒童醫院的RVS病例也已增加了2倍。 RSV病毒的癥狀，包括流鼻涕、咳嗽、發燒或喉嚨痛，大多數兒童在2歲左右時會接觸一次RSV病毒，對大多數孩子來說，這種病毒非常溫和，與通過空氣傳播的covid病毒不同，大多是通過表面接觸傳播，勤洗手及避免接觸有感冒癥狀的患者，對防治這種病毒非常有效。
感染RSV病毒后，嬰兒看起來可能昏昏欲睡，食慾不佳，這可能是他們感到難受的第一個階段。 他們可能會覺得呼吸困難。 可能發燒，也可能不發燒。 父母們需要注意這些早期的跡象：食欲不振和呼吸困難。 醫療保健專家比較擔心，當進入冬季時，RSV、流感和covid病毒的三者結合，這三種病毒以及其它病毒的重疊，一定是以後幾個月的大問題。
2022-11-2203 min20-Minute Health TalkRSV: What parents need to know about the surge of this airway infectionTypically, respiratory syncytial virus (RSV) sends thousands of children to the hospital over fall and winter, peaking in January and February. But for the second year in a row cases have spiked early and continue to grow. This has led to unprecedented cases of the common respiratory virus across the U.S. On this episode, Cohen Children's Medical Center leaders Joshua Rocker, MD, and Margaret Duffy, PhD, RN, NEA-BC, discuss what they are seeing on the front lines in New York, the impact flu will have leading into the winter months, and how hospitals are responding to the need...
2022-11-1720 min
Science FridayThe US Battles RSV, Neural Connections, La Brea Tar Pits. Nov 11, 2022, Part 2How Past Extinctions At The La Brea Tar Pit Can Teach Us About Our Climate Future
If you drive through Los Angeles, you’ll pass by some of California’s most iconic sites—the Hollywood Walk of Fame, Universal Studios, the Santa Monica Pier. But if you don’t look for it, you may miss the La Brea tar pits—a place where Ice Age life from around 50 thousand years ago got trapped and preserved in sticky black ooze. Visitors can see megafauna, including skeletons of saber tooth cats and dire wolves, along with a vast collection of specime...
2022-11-1147 min
Mom And Doc Talk PodcastRSV Is Surging In Infants And Children - What You Need To Know As A ParentRSV is also known as Respiratory Syncytial Virus. The season for RSV is typically late fall (November/December) through early spring but this year it began earlier in combination with several other active viruses (Rhinovirus, Influenza A, Covid-19). As a result, it is not only causing illness infants and children but overwhelming hospitals and emergency departments.
What is RSV
RSV is a viral (not treated with antibiotics) infection that causes cold like symptoms (runny nose, sneezing, fever, sore throat) as well as impacting the lungs resulting in cough, wheezing, increased work of breathing and sometimes se...
2022-11-0835 min
The Clinical Concepts PodcastRespiratory Syncytial Virus (RSV)The 2022 cold and flu season is off and running! Thus far emergency departments and EMS systems alike are caring for more RSV patients, than ever before, for this early in the season. But what is RSV anyway? Join me as we take a dive into the pathophysiology and management of this virus and discuss the brain-tips to fingertips facts that every EMS provider should know when caring for the critically ill RSV patient of any age.We want to hear from you! For additional information:Follow us on Facebook: https://www.facebook.com...
2022-10-3025 min